 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval2 Q" J8 I F' ?5 d: T2 R5 L
6 n! u3 p: g7 F) e0 H3 Z2 b& `
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
/ D! h! V: s" m- W5 I* r 5 D- L& T3 K6 h0 p0 A' s0 r
BY THE EDMONTON JOURNAL FEBRUARY 16, 20070 L6 t7 V! c/ X2 p
- s# M; C# b$ k
' x' A9 L% Q1 S0 P5 h/ F2 X. gEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
/ t9 v/ [- {6 {/ q
$ E ^4 {3 @) E/ z9 |The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."! h" Y: g/ h( Z2 ?; Y
, ~1 K9 ?, a. d: xThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
* X4 I6 U+ b# F8 ~
6 E( M+ q( J$ g3 cIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.: ]9 W7 p$ i; Q# z1 { ]
4 }" u1 h6 p6 B& t+ Z& P( a7 d2 k
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.& T" Q) \* M6 G* n/ U8 ?1 I5 n! d
8 g7 i& Q6 k! P( a8 B3 T
"As a scientist, it's one of the highlights of my CAREER," Shan said.! m) o+ M2 A! h! [) G! E) L
- j, w1 h" p; S. | Y. w" T
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
0 X1 t/ [# E0 P9 z+ S! D
; E0 ]! z& \" J4 f# Y5 aIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
4 u4 R$ m/ O: ~ c z7 s, `5 p; e3 V4 }0 H
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
: J* h5 e& l. H+ ?
( H# m/ ]$ s! }5 D" l+ m- eThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
) |9 x8 k$ }' D$ F- z5 c: e* ]4 w+ Y7 z0 Q/ D' h& _# _
0 Q, Z$ V1 d' Q+ k0 }! zhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
